JDB电子·「中国」官方网站

      SARS-CoV-2 (COVID - 19) IgM/IgG

      SARS-CoV-2 (COVID-19) IgM/IgG Ab Rapid Test

       

      - Specimen: Whole Blood/Serum/Plasma

      - Fast Reaction: 15 minutes

      - IgM Sensitivity: 82%

      - IgM Specificity: 97%

      - IgG Sensitivity: 93%

      - IgG Specificity: 97.5%


      • Introduction
      • Manual
      • Intrusctions

      The SARS-CoV-2 IgM/IgG Ab Rapid Test is used to detect the IgM and IgG antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human serum, plasma or whole blood sample qualitatively. It it to be used as an aid in the diagnosis of coronavirus infection disease (COVID-19), which is caused by SARS-CoV-2.


      The test provides preliminary test results. Negative results don't preclude SARS-CoV-2 infection and they cannot be used as the sole basis for treatment or other management decision.


      COVID-19, it is a novel coronavirus with new strain thathas not been previously identified in humans, belongs to Coronaviruses (CoV) suchas Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome(SARS-CoV).


      Product NameSpecimenFormatKit size

      SARS-CoV-2 IgM/IgG Ab 

      Rapid Test

      WB/S/PCassette40T/box, 48 boxes/ctn


      Please contact us for any enquiries.

      Email: sales@hightopbio.com




      Copyright © HIGHTOP Biotech
      友情链接: